Phoenix Business Consulting invests in telehealth platform Healpha The missing informal workers in India’s vaccine story Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Leading global experts in interventional cardiology recently participated and shared their breaking clinical trials, researches, latest evidence-based medicine, latest technologies and innovations iat the 32nd global annual scientific symposium, Transcatheter Cardiovascular TherapeuticsIncreasing cardiovascular burden globally and the need for innovative technologies has changed the face of heart care today. With the changing lifestyles and the current pandemic leaving an impact on the heart, the situation has become more complex. This has led cardiologists to push the envelope and find new ways to treat patients. Leading experts from the various fields of interventional cardiology from across the globe including scientists, radiologists, clinical cardiologists, vascular medicine specialists, cardiac and vascular surgeons recently participated and shared their breaking clinical trials, researches, latest evidence-based medicine, latest technologies and innovations in the field of intervention at the 32nd global annual scientific symposium, Transcatheter Cardiovascular Therapeutics.One of the key topics discussed at the global platform was the result of clinical trial on imaging iOPTICO from India. iOPTICO is based on Optical Coherence Tomography (OCT), the latest imaging technology in the field of coronary intervention. For many years, angiography has been the medium of guidance for percutaneous coronary interventions (PCI) but could only provide limited information of the diseased coronary arteries. But, the latest imaging technology, OCT comes with an enhanced visualisation and high-resolution imaging, which helps in accurate decision making, strategising the procedure precisely and optimise the outcome, thus leading to a PRECESION PCI with better patient outcomes.The trial involved 500 patients, who were enrolled between November 2018 to March 2020 from nine locations across India and Bangladesh. The patients were selected for the study, if they had significant coronary artery stenosis (diameter stenosis >70 per cent based on visual assessment on the coronary angiogram) in at least one native coronary artery after angiography. The primary objective was to assess the change in treatment strategy pre and post PCI (percutaneous coronary intervention). Pre-PCI strategy change involved need for lesion preparation, change in the intended stent length and size, and intended device landing zone. Post-PCI strategy change involved the intended need for additional interventional procedures for PCI optimisation after identification of stent malaposition, edge dissections, and stent under expansion. This was the first South Asian study reporting the outcomes of OCT-ACR (Angiographic co-registered) guided PCI in patients with coronary artery disease.The key findings of the study were that when OCT was used along with angiography, it changed the angiographic based decisions in 90 per cent of the lesions in the patients who underwent the trial. Cardiologists changed their strategy in 86 per cent of lesions before PCI and 30 per cent of lesions after PCI.The primary investigator (PI) of iOPTICO, Dr. Rony Mathew (HOD & Senior Consultant, Lisie Cardiology Dept) shed light on the technology and said, “OCT is the new approach to PCI procedure as it helps an operator see better and get all the information inside the diseased coronary artery. In this study, when OCT was used along with angiography, it changed the angiographic based decision in 90 per cent of the lesions in trial patients. It enhances decision making through precision and accuracy.”Referring to a recently presented US clinical trial LightLab data, site investigator of the trial Dr. Balbir Singh, Chairman and Head, Cardiology for Max Healthcare group highlighted, “The field of Interventional cardiology is getting more advanced and is culminating towards perfection or PRECESION PCI and both Indian iOPTICO and US LightLab data shows similar change in the PCI strategy in spite of varied demography and clinical setup. The LightLab data has shown a cumulative impact of decision change with OCT on 88 per cent of the lesions, with pre-PCI OCT impact of 83 per cent and post-PCI OCT impact of 31 per cent of the lesions in the study patients compared to angiography.”Another site investigator Dr Samuel Mathew, Director – Cardiac Cath Lab, Apollo Hospitals, Chennai (Chief consultant & Lilavati Hospital) who is known as the pioneer and Father of Angioplasty in India emphasised, “Intravascular imaging (IVI) guided percutaneous coronary intervention (PCI) has shown to be associated with superior outcomes compared to angiography-based PCI. Optical coherence tomography (OCT) is a high-resolution IVI modality used widely for PCI optimisation. The current iOPTICO study was designed to evaluate the utility newer angiography – OCT co-registration (ACR) workflow in PCI optimisation in a population of 500 Indian patients. This first South Asian study iOPTICO will open up new dimensions in the field of intervention cardiology and will solely benefit the patients with coronary artery disease as cardiologists will see with clarity and treat with certainty leading to excellent clinical outcome.”Other investigators from India and Bangladesh included eminent cardiologists such as Dr. Jabir A, Senior Consultant and Director of Clinical Research (Cardiology) at Lisie Cardiology Dept, Dr. Tejas Patel, Chairman and Chief Interventional Cardiologist at Apex Heart Institute, Dr. Balbir Singh, Chairman N Head, Cardiology at Max Healthcare, Dr. Nagendra SC, Director – Department of Interventional Cardiology in Medanta-The Medicity, Gurugram, Prof Fazila-Tun-Nesa Malik Cardiology Specialist at National Heart Foundation Hospital and Research Institute, Dhaka, Dr. Shirish (M.S) Hiremath, Director, Cathlab, Ruby Hall Pune, Dr. G. Sengottuvelu-Senior Consultant and Interventional Cardiologist at Apollo Hospitals, Chennai, Dr. Samuel Mathew, Chief Interventional Cardiologist, Apollo Hospital Chennai and Lilavati Hospital and Research Centre, Mumbai, Dr. Viveka Kumar, Principal Director & Chief of Cath Labs, Max Healthcare, Dr. Vijayakumar, Cardiologist at The Madras Medical Mission Hospital and Dr. Shivakumar, Senior Consultant Cardiologist at Meenakshi Mission Hospital & Research Centre (MMHRC) Madurai; for their continuous support and efforts for making this clinical trial successful. Menopause to become the next game-changer in global femtech solutions industry by 2025 Cardiac Care News Radiology Adoption of AI/ML can disrupt healthcare services MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Read Article Innovative imaging technology promises improved cardiac care Add Comment WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals By EH News Bureau on November 10, 2020 Related Posts cardiac carecardiovascular burdenImaging technologyTranscatheter Cardiovascular Therapeutics Share Comments (0)
RelatedJamaicans honoured in Huddersfield Jamaicans honoured in Huddersfield Foreign AffairsOctober 26, 2010 RelatedJamaicans honoured in Huddersfield FacebookTwitterWhatsAppEmail Fourteen Jamaicans and other Caribbean nationals were honoured recently in Huddersfield, in the north of England, at a special awards ceremony, held to recognise local heroes and heroines as part of celebrations to mark Black History Month and the 20th anniversary of the Jamaica National Council (Huddersfield)High Commissioner to the United Kingdom (UK), His Excellency Anthony Johnson who was special guest at the ceremony, congratulated the awardees, and commended them for the contributions they have made in building their local communities. “You have all done well and deserved to be recognized,” he said.The awards ceremony, hosted by the Jamaica National Council (Huddersfield) and the Shabach Outreach Ministries, gave the community an opportunity to recognise local members who have given voluntary service to the Borough of Kirklees (where Huddersfield is located).High Commissioner to the United Kingdom, His Excellency Anthony Johnson (right), in discussion with the Mayor of Kirklees(where Huddersfield is located), Councillor Andrew Palfreeman. This was the High Commissioner’s first official visit to Huddersfield.High Commissioner Johnson lauded the community for keeping the Diaspora together and urged them to keep their Jamaican heritage alive for the second and third generations. He also encouraged them to invest in businesses, so that they can be independent and continue to support Jamaica.It was High Commissioner Johnson’s first official visit to Huddersfield and he and his wife Pamela were given a red carpet welcome, with local school children singing Jamaica’s National Anthem.During his visit the High Commissioner also met with the Mayor of Kirklees, Councillor Andrew Palfreeman, at which he proposed the possibility of developing projects between Huddersfield and Jamaica. The Mayor was receptive to the idea and promised to have his International Relations team examine the possibilities. Advertisements RelatedJamaicans honoured in Huddersfield
The Nigerian Army on Thursday said government forces had killed five top commanders of terror group Boko Haram as troops intensify efforts to smoke out their remnants in the northeast region.Army spokesman Sani Usman said in a statement that a “large number” of Boko Haram fighters and their leaders were neutralized in artillery bombardment and air strike by the government forces.The operation, undertaken based on credible intelligence information, targeted Boko Haram hideouts, according to the army spokesman.“The Nigerian military would continue with the concerted onslaught on the reported Boko Haram terrorists’ locations till they have been eliminated,” he said.Boko Haram has killed more than 20,000 people and displaced 2.3 million others since its emergence in 2009.